Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP873091.RAU2AU7wnIicQO93YB35Qosg7QOczxGvqAlfHfWWCDz04130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP873091.RAU2AU7wnIicQO93YB35Qosg7QOczxGvqAlfHfWWCDz04130_assertion type Assertion NP873091.RAU2AU7wnIicQO93YB35Qosg7QOczxGvqAlfHfWWCDz04130_head.
- NP873091.RAU2AU7wnIicQO93YB35Qosg7QOczxGvqAlfHfWWCDz04130_assertion description "[We conclude that lenalidomide has the potential to induce sustained hematological and cytogenetic remissions in the poor prognosis MDS subgroup of del(5q31) patients with complex chromosomal anomalies and that this is likely to improve overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873091.RAU2AU7wnIicQO93YB35Qosg7QOczxGvqAlfHfWWCDz04130_provenance.
- NP873091.RAU2AU7wnIicQO93YB35Qosg7QOczxGvqAlfHfWWCDz04130_assertion evidence source_evidence_literature NP873091.RAU2AU7wnIicQO93YB35Qosg7QOczxGvqAlfHfWWCDz04130_provenance.
- NP873091.RAU2AU7wnIicQO93YB35Qosg7QOczxGvqAlfHfWWCDz04130_assertion SIO_000772 15891887 NP873091.RAU2AU7wnIicQO93YB35Qosg7QOczxGvqAlfHfWWCDz04130_provenance.
- NP873091.RAU2AU7wnIicQO93YB35Qosg7QOczxGvqAlfHfWWCDz04130_assertion wasDerivedFrom befree-20150227 NP873091.RAU2AU7wnIicQO93YB35Qosg7QOczxGvqAlfHfWWCDz04130_provenance.
- NP873091.RAU2AU7wnIicQO93YB35Qosg7QOczxGvqAlfHfWWCDz04130_assertion wasGeneratedBy ECO_0000203 NP873091.RAU2AU7wnIicQO93YB35Qosg7QOczxGvqAlfHfWWCDz04130_provenance.